Trial intelligence / Profile preview

High-Dose Levofloxacin for Complicated UTI

NCT00245791Phase 4Terminated

Sponsor
University of Manitoba
Start
Oct 2004
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of levofloxacin in complicated urinary tract infection (cUTI), sponsored by University of Manitoba. Started Oct 2004; status: terminated.

02

Drugs

levofloxacin
03

Conditions

complicated urinary tract infection (cUTI)

Beyond the preview

Go deeper on NCT00245791.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00245791.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call